Haemonetics Corp HAE

US Health Care

$105.80 ▲ +0.01% (+$0.01)

Open $104.99

Prev Close $105.79

Day Range $104.60 – $106.52

52W Range $47.32 – $110.45

Market Cap $4.81B

P/E (TTM) 49.75

Beta 0.66

EPS (TTM) $2.05

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1979-10-17
Shares Out.	45,450,000
Website	haemonetics.com ↗
Phone	17818487100
Employees	3,009
Revenue	$339.4M
Gross Profit	$202.8M
Net Income	$33.0M
Free Cash Flow	$245.2M
Total Assets	$2.37B
Total Liabilities	$1.53B
Equity	$837.1M

About Haemonetics Corp

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Haemonetics Corp is a publicly traded company under the ticker symbol HAE on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.